BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2898943)

  • 1. Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein.
    Broxterman HJ; Kuiper CM; Schuurhuis GJ; Tsuruo T; Pinedo HM; Lankelma J
    Biochem Pharmacol; 1988 Jun; 37(12):2389-93. PubMed ID: 2898943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells.
    Sehested M; Bindslev N; Demant EJ; Skovsgaard T; Jensen PB
    Biochem Pharmacol; 1989 Sep; 38(18):3017-27. PubMed ID: 2571333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic free Ca2+ in daunorubicin and vincristine resistant Ehrlich ascites tumor cells. Drug accumulation is independent of intracellular Ca2+ changes.
    Bouchelouche P; Friche E; Sehested M; Jensen PB; Skovsgaard T
    Biochem Pharmacol; 1991 Jan; 41(2):243-53. PubMed ID: 1899193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistance.
    Broxterman HJ; Pinedo HM; Kuiper CM; van der Hoeven JJ; de Lange P; Quak JJ; Scheper RJ; Keizer HG; Schuurhuis GJ; Lankelma J
    Int J Cancer; 1989 Feb; 43(2):340-3. PubMed ID: 2563722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
    Sehested M; Skovsgaard T; Jensen PB; Demant EJ; Friche E; Bindslev N
    Br J Cancer; 1990 Jul; 62(1):37-41. PubMed ID: 1975202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient.
    Lankelma J; Spoelstra EC; Dekker H; Broxterman HJ
    Biochim Biophys Acta; 1990 Dec; 1055(3):217-22. PubMed ID: 1979920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
    Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
    J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
    Chiang CD; Song EJ; Yang VC; Chao CC
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
    Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
    Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
    Nielsen D; Maare C; Eriksen J; Litman T; Skovsgaard T
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1050-7. PubMed ID: 11704330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil and cyclosporin A potentiate the effects of chemotherapeutic drugs in the human medullary thyroid carcinoma TT cell line not expressing the 170 kDa P-glycoprotein.
    Larsson R; Nygren P
    Cancer Lett; 1990 Nov; 54(3):125-31. PubMed ID: 1977512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein binding.
    Broxterman HJ; Kuiper CM; Schuurhuis GJ; van der Hoeven JJ; Pinedo HM; Lankelma J
    Cancer Lett; 1987 Apr; 35(1):87-95. PubMed ID: 3471315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
    Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
    Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
    Pieters R; Hongo T; Loonen AH; Huismans DR; Broxterman HJ; Hählen K; Veerman AJ
    Br J Cancer; 1992 May; 65(5):691-7. PubMed ID: 1350207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators.
    Sehested M; Jensen PB; Skovsgaard T; Bindslev N; Demant EJ; Friche E; Vindeløv L
    Br J Cancer; 1989 Dec; 60(6):809-14. PubMed ID: 2605092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
    Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
    J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.
    Naito M; Tsuge H; Kuroko C; Tomida A; Tsuruo T
    Jpn J Cancer Res; 1993 May; 84(5):489-92. PubMed ID: 8100562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
    Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
    Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric double labeling technique for screening of multidrug resistance.
    Gheuens EE; van Bockstaele DR; van der Keur M; Tanke HJ; van Oosterom AT; De Bruijn EA
    Cytometry; 1991; 12(7):636-44. PubMed ID: 1685985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.